Prous Institute has been invited to speak at the 136th Annual Meeting of the Pharmaceutical Society ofJapan (March 26-29, 2016) to be held at the Pacifico Yokohama Conference Center.

The Pharmaceutical Society of Japan promotes the development of pharmaceutical sciences among its more than 20,000 members, which include chemists, physicists, biologists, and a wide profile of life science specialists who contribute to health and welfare through creating, producing, supplying and prescribing medicines.

During the event, Josep Prous, Jr., Ph.D., Vice President Research and Development, will present “Knowledge Management Challenges in Modern Drug Discovery”, highlighting the applications of predictive technologies in biomedical research.

The talk is included in the symposia “Strategic In Silico Approach to Overcome Drug Development Stalemate” organized by Prof. Noriaki Hirayama from Tokai University

Dr Prous, Jr. commented: “we are very pleased to participate in this prestigious conference and be able to share with this audience of pharmaceutical researchers how in silico solutions can help prioritize clinical candidates by identifying toxicity and safety issues early in the development cycle.”

For further information or to schedule a meeting during the conference, please contact symmetry@prousresearch.com.